1564
J. P. Colomer, E. L. Moyano / Tetrahedron Letters 52 (2011) 1561–1565
O
HN
N
CN
NC
NH2
O
N
NH
N
NaNO2
HCl/AcOH
N
N
N
+
+
N
NH2
N
N
N
5
N
N
0-5 °C to r.t.
24h
ROESY
Ph
1d
Ph
3d
Ph
Ph
12
Scheme 4. Diazotization of a mixture of 3d and 5.
R
H
OEt
CN
CN
CN
H
NH
H2N
H2N
CN
CN
HC(OEt)3
H2N
R
N
KOH, 1M
N
N
CN
NH2
Dioxane
EtOH
N
R
r.t.
H2N
H2N
CN
2a (90%)
2b (98%)
2c (74%)
14
15a R= p-CH3Ph (52%)
15b R= p-OCH3Ph (80%)
15c R= p-ClPh (39%)
13
Scheme 5. Synthesis of 5-amino-1H-imidazole-4-carbonitriles.
O
Compounds 4a–c and their precursors were synthesized by
methodologies described in the literature.19
NaNO2
CN
NH2
NH
N
N
HCl/ AcOH
0-5 ºC to r.t.
N
N
Acknowledgments
N
R
N
R
Financial support from CONICET and SECyT-UNC is gratefully
acknowledged. The authors are grateful for the contribution of
Ph.D. Walter J. Peláez.
4a-c
2a R= p-CH3Ph
2b R= p-OCH3Ph
2c R= p-ClPh
Scheme 6. Synthesis of imidazo[4,5-d][1,2,3]triazin-4-ones.
Supplementary data
Supplementary data (experimental procedure and analyzes
data of compounds 1b–d, 2a–c, 3b–d, 4a–c, 5, 9a–d, 10a–d, 11a,
11d and 12 are presented) associated with this article can be
Table 3
Yields of formation of imidazotriazinones 4
Compd
R
Yielda (%)
4a
4b
4c
p-CH3Ph
p-OCH3Ph
p-ClPh
56
90
41
References and notes
a
1. Kelley, J.; Wilson, D.; Styles, V.; Soroko, F.; Cooper, B. J. Heterocycl. Chem. 1995,
32, 1417–1421.
Isolated yields.
2. Simons, C. In Nucleoside Mimetics: Their Chemistry and Biological Properties
(Advanced Chemistry Texts); Gordon and Breach Science Publishers:
Amsterdam, 2001; Vol. 4, pp 83–102 and references cited therein.
3. Isono, K. Pharmacol. Ther. 1991, 52, 269–286.
4. Woolley, D.; Shaw, E. J. Biol. Chem. 1951, 189, 401–410.
5. De Clercq, E. Nat. Rev. Drug Discovery 2002, 1, 13–25.
6. Seela, F.; Lindner, M.; Glaçon, V.; Lin, W. J. Org. Chem. 2004, 69, 4695–4700.
7. Kelly, J.; Wilson, D.; Styles, V.; Soroko, H.; Hunt, J.; Briggs, E.; Clarke, E.;
Whittingham, W. Bioorg. Med. Chem. Lett. 2007, 17, 5222–5226.
8. Migawa, M.; Townsend, L. J. Org. Chem. 2001, 66, 4776–4782.
9. Migawa, M.; Drach, J.; Townsend, L. J. Med. Chem. 2005, 48, 3840–3851.
10. (a) Montgomery, J.; Laseter, A.; Shortnacy, A.; Clayton, S.; Thomas, H. J. Med.
Chem. 1975, 18, 564–567; (b) Li, H.; Zhu, Y.; Song, X.; Hu, F.; Liu, B.; Li, Y.; Niu,
Z.; Liu, P.; Wang, Z.; Song, H.; Zou, X.; Yang, H. J. Agric. Food. Chem. 2008, 56,
9535–9542; (c) Harb, A.; Abbas, H.; Mostafa, F. J. Iranian Chem. Soc. 2005, 2,
115–123; (d) Dawood, K.; Farag, A.; Khedr, N. Arkivoc 2008, XV, 166–175; (e)
Andersen, K.; Pedersen, E. Liebigs Ann. Chem. 1986, 1012–1020; (f) Sugiyama,
T.; Schweinberger, E.; Kazimierczuk, Z.; Ramzaeva, N.; Rosemeyer, H.; Seela, F.
Chem. Eur. J. 2000, 6, 369–378.
In addition, 5-amino-1-benzyl-1H-pyrazole-4-carbonitrile 1d
was selectively obtained when benzylhydrazine dihydrochloride
was neutralized with only one equivalent of base disregarding
the nature of the base used. Alternatively, the regioisomer 5 was
obtained as side product when two equivalents of base were used
in the neutralization of hydrochloride salt. Aminopyrazole 5 also
formed the corresponding pyrazolotriazine under diazotization
conditions expanding the application of the methodology here
described.
4. Experimental section
General: NMR spectra were recorded with Bruker AC 200 and
400 spectrometers. Chemical shifts are reported in ppm relative
to internal TMS. All chemicals were of reagent grade and used
without purification. High-resolution mass spectra were recorded
with an Agilent LCTOF instrument. Column chromatography was
carried out on grade 60 silica gel (70–230). Compounds 3a–d were
prepared from monosubstituted hydrazine (3a), monosubstituted
hydrazine hydrochlorides (3b and 3c), or monosubstituted hydra-
zine dihydrochloride (3d) and ethoxymethylenemalononitrile, by
the methodology described in the literature.11
11. Moyano, E.; Colomer, J.; Yranzo, G. Eur. J. Org. Chem. 2008, 19, 3377–3381.
12. Cheng, C.; Robins, R. J. Org. Chem. 1956, 21, 1240–1256.
13. Elguero, J. In Comprehensive Heterocyclic Chemistry II; Katritzky, A., Rees, C.,
Scriven, E., Eds.; Elsevier, 1996; Vol. 3.01, pp 1–75. and references cited herein.
14. López Rivilli, M.; Moyano, E.; Yranzo, G. Tetrahedron Lett. 2010, 51, 478–481.
15. Kelley, J.; Davis, R.; McLean, E.; Glen, R.; Soroko, F.; Cooper, B. J. Med. Chem.
1995, 38, 3884–3888.
16. General procedure for diazotization of aminopyrazoles 1a–d and
aminoimidazoles 2a–c: Aqueous NaNO2 (1.8 mmol, 1 mL) was added to a
well-stirred and cooled solution (0–5 °C) of pyrazole or imidazole (1 mmol) in
a mixture of HCl/AcOH (3:1, 20 mL) over a period of 10 min. The reaction
mixture was allowed to warm at room temperature and was stirred for 20 h.